Corrigendum to “Ascorbyl palmitate ameliorates inflammatory diseases by inhibition of NLRP3 inflammasome” [Int. Immunopharmacol. 131 (2024) 111915]

Autor: Zhang, Luchen, Li, Guoyang, Lin, Bolong, He, Hongbin, Zhou, Rongbin, Jiang, Wei
Zdroj: In International Immunopharmacology 10 September 2024 138
Databáze: ScienceDirect